synthetic biology: the next generation of biotechnology - christina smolke, stanford engineering

Post on 18-Dec-2014

2.335 Views

Category:

Education

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

Stanford Engineering Professor Christina Smolke explains how advances in synthetic biology are revolutionizing medical treatment, prevention and diagnosis of disease. She made this presentation at the school's annual eDay (Engineering Day) event.

TRANSCRIPT

July 16, 2011 12th Annual eDay

Christina D. Smolke Department of Bioengineering Stanford University

Natural chemicals and materials

Taxus brevifolia (pacific yew) taxol

Papaver somniferum (opium poppy) codeine, morphine

spider silk

Clostridium acetobutylicum butanol

Hevea brasiliensis (rubber tree) rubber

Microbial biofactories

Taxus brevifolia (pacific yew) taxol

Papaver somniferum (opium poppy) codeine, morphine

spider silk

Clostridium acetobutylicum butanol

Hevea brasiliensis (rubber tree) rubber

New chemicals raw materials microbial fermentation

genetic materials,

manipulation & control

materials products

www.neurooncologia.com

Intelligent therapeutics

Apps Tools

c/o D. Endy (Stanford University)

1. Info. theory & signal proc. 2. Device design

7. Control & dyn. systems

5. Fab, CAD & EDA 6. Reverse engineering

3. Languages & grammars 4. Standards & abstraction

c/o D. Endy (Stanford University)

signal processing automated response dynamic control

Circuitry remote control memory communication

Actuators (Outputs) reporting delivery motility

phenotype self-organization synthesis

Sensors (Inputs) chemicals biomolecules temperature light

Engineering systems

Synthetic biology

signal processing automated response dynamic control

Circuitry remote control memory communication

Actuators (Outputs) reporting delivery motility

phenotype self-organization synthesis

Sensors (Inputs) chemicals biomolecules temperature light

Ongoing tools revolution DNA Sequencing

Read Out the Genetic Code

Recombinant DNA

Basic “Cut” & “Paste”

Polymerase Chain Reaction

Amplify & Make Simple Changes

First Gen. Biotech =

...

Next Gen. Biotech Adds New Tools

=

c/o D. Endy (Stanford University)

Transformative advances in fabrication platforms

Cellular assembly Carr PA, Church GM. 2009. Nat Biotech. 27: 1151-1162

genome transplantation

natural

engineered

Gibson DG, et al. 2010. Science. 329: 52-6

Now that we can write in DNA, what

do we say?

Challenge: Design Gap

Molecular computers enable programming of function input

output

input A

outp

ut

sensor1 / transmitter1 / actuator

input A

outp

ut

sensor1 / transmitter2 / actuator

input B

outp

ut

sensor2 / transmitter1 / actuator

input output

Win MN, Smolke CD. 2007. PNAS. 104: 14283-8

Molecular computers enable programming of function input

output

input A

outp

ut

sensor1 / transmitter1 / actuator

input A

outp

ut

sensor1 / transmitter2 / actuator

input B

outp

ut

sensor2 / transmitter1 / actuator

A B output

0 0 1 0 1 1

1 0 1 1 1 0

n sensors / n transmitters / actuator

Win MN, Smolke CD. 2008. Science. 322: 456-60

Decoupling & abstraction lead to powerful technology platforms

Win MN, Liang JC, Smolke CD. 2009. Chem Biol. 16: 298-310

harvesting and refining from nature

rational computer- aided design (CAD)

evolving new functions

Building scalable bio-manufacturing platforms

anti-malarial

analgesics

anticancer

antimicrobial

hair growth

anti-HIV

Integrating into a microbial host

Hawkins KM, Smolke CD. 2008. Nat Chem Biol. 4: 564-73

Harvesting natural diversity

Building a microbial drug factory

Enzymes catalyze reactions:

Morphinan Alkaloids

Sanguinarine / Berberine Alkaloids

Bis-BIAs

Building a microbial drug factory

Morphinan Alkaloids

Sanguinarine / Berberine Alkaloids

Bis-BIAs

Building a microbial drug factory

DNA

protein

metabolite

Morphinan Alkaloids

Sanguinarine / Berberine Alkaloids

Bis-BIAs

Building a microbial drug factory

Morphinan Alkaloids

Sanguinarine / Berberine Alkaloids

Bis-BIAs

Building a microbial drug factory

Morphinan Alkaloids

Sanguinarine / Berberine Alkaloids

Bis-BIAs

Building a microbial drug factory

Integrated systems design of microbial factories

SalR-GFP SalAT-mCherry

Vacuole

Nucleus

ER

Mitochondrion

Golgi

Synthesome

pH 4-5

pH 8-9

degradation

pH 7-8

input A

outp

ut

Targeting biosynthesis to specialized compartments

Noninvasive detection of chemical synthesis

Building autonomous control systems

Culler SJ, Hoff KG, Smolke CD. 2010. Science. 330: 1251-5

Molecular computers can rewire disease pathways

Culler SC, Hoff KG, Smolke CD. 2010. Science. 330: 1251-5

!"#$%&

'

(

)

!

*

+,-./,0

123 )04/5

678 & 3 9 : ; 8 < = > &? && &3 67= @!A67<

6

4/.BC"D/%!E.5%67FG/00"E+

9H00%5/D"-/ ;H00%5/D"-/

I

I

II

I

I II

I

A.BCJEGK%L%123M)04/5

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#A.BCJEGK%L%123M)04/5

4/.BC"D/%67-.NO+-.

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#

I

I

I

II

I

I

I

O+CGE+%FE0"C"E+

9H00%5/D"-/ ;H00%5/D"-/

' *

( FGE."J/GBC"E+

"+F,C%0"#+B.

PBC"D/%P/CQEGR

'.C/G/5%P/CQEGR

' *

(

"+F,C%0"#+B.

)

!"#$%&

-/..%5/BCS!"#$%'

"+F,C%KE5,./

FGEC/"+%0/+0EG

B-C,BCEG%KE5,./

$+,, &+,,

/7E+%/7-.,0"E+

TS"#S%5/D"-/

E,CF,CU

B.C/G+BC"D/%/7E+%"+-.,0"E+

L L

E,CF,C%KE5,./

#/+/%EJ%"+C/G/0C

@VO

B00/KW./5%4P'%5/D"-/

@VO

XS/%"5/+C"CY%EJ%CS/%4P'%0/+0EG%B+5%"C0%.E-BC"E+%"+%CS/%"+CGE+"-%

0FB-/%Q"..%5/C/GK"+/%CS/%/JJ/-C%

EJ%"+F,C%W"+5"+#%E+%CS/%5/D"-/%

E,CF,C$

/7E+%"+-.,0"E+

T.EQ%5/D"-/%

E,CF,CU

)04/5 123M)04/5 )04/5 123M)04/5

123M9%)/D"-/

)04/5

@!A

1/G#/5

123!M9%)/D"-/

@VO

@VO

.EQ%E,CF,C

S"#S%E,CF,C

9H00

5/D"-/

+,-./,0

FGEC/"+%

"+F,C

@VO

!"#$%&

'

(

)

!

*

+,-./,0

123 )04/5

678 & 3 9 : ; 8 < = > &? && &3 67= @!A67<

6

4/.BC"D/%!E.5%67FG/00"E+

9H00%5/D"-/ ;H00%5/D"-/

I

I

II

I

I II

I

A.BCJEGK%L%123M)04/5

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#A.BCJEGK%L%123M)04/5

4/.BC"D/%67-.NO+-.

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#

I

I

I

II

I

I

I

O+CGE+%FE0"C"E+

9H00%5/D"-/ ;H00%5/D"-/

' *

( FGE."J/GBC"E+

"+F,C%0"#+B.

PBC"D/%P/CQEGR

'.C/G/5%P/CQEGR

' *

(

"+F,C%0"#+B.

)

!"#$%&

-/..%5/BCS!"#$%'

"+F,C%KE5,./

FGEC/"+%0/+0EG

B-C,BCEG%KE5,./

$+,, &+,,

/7E+%/7-.,0"E+

TS"#S%5/D"-/

E,CF,CU

B.C/G+BC"D/%/7E+%"+-.,0"E+

L L

E,CF,C%KE5,./

#/+/%EJ%"+C/G/0C

@VO

B00/KW./5%4P'%5/D"-/

@VO

XS/%"5/+C"CY%EJ%CS/%4P'%0/+0EG%B+5%"C0%.E-BC"E+%"+%CS/%"+CGE+"-%

0FB-/%Q"..%5/C/GK"+/%CS/%/JJ/-C%

EJ%"+F,C%W"+5"+#%E+%CS/%5/D"-/%

E,CF,C$

/7E+%"+-.,0"E+

T.EQ%5/D"-/%

E,CF,CU

)04/5 123M)04/5 )04/5 123M)04/5

123M9%)/D"-/

)04/5

@!A

1/G#/5

123!M9%)/D"-/

@VO

@VO

.EQ%E,CF,C

S"#S%E,CF,C

9H00

5/D"-/

+,-./,0

FGEC/"+%

"+F,C

@VO

Native Network

Altered Network

!"#$%&

' (

)

!

"

#

! "# #$ %& $'

()!*"+,%

()!*#+,%

(&),%

*"+,%-./

0,123"4,%,567,88"9:%-;91</

=

=

*"+,%-./

!

"

#

! "# #$ %& $'

-,./0,%-,./0,1

0,123"4,%,567,88"9:%-;91</

==!,./0,&!,./0,%

!

"

#

-,./0,% -,./0,&

0,123"4,%,5>1?":>1

@,4">,

2/034

567$

!,./0,% !,./0,&

==

=

A

!

@

!

"

()!*"+,% ()!*#+,%

@,4">,

0,123"4,%,567,88"9:

= =

7893:

()!,7893:

B

*C!0

*C!!

DE"

F

6GH 6IG

DE"

6GH 6IG

JKJKJKJK

L!F

L!F

M"#.%9N36N3

CN>1,N8

L!F

O9P%9N36N3

(5I (5Q (5R

6GH @80,<

B L!F

CN>1,N8

(5I (5Q (5R

BSI

O*@T

AU8O*V

'W3

"X>23,:":F

LYEB

L!F

L!F

M"#.%9N36N3

CN>1,N8

L!F

O9P%9N36N3

(5I (5Q (5R

Z23,7 *C!X! Z23,7 *C!X!

F.28,

L!F

6IGXB%<,4">, 6IG#XB%<,4">,

!

"

#

%

$

()!*"+,% ()!*#+,% (&),%

0,123"4,%%,5>1?":>1

@,4">,

2/034

6;<,"=

!"#$%&

' (

)

!

"

#

! "# #$ %& $'

()!*"+,%

()!*#+,%

(&),%

*"+,%-./

0,123"4,%,567,88"9:%-;91</

=

=

*"+,%-./

!

"

#

! "# #$ %& $'

-,./0,%-,./0,1

0,123"4,%,567,88"9:%-;91</

==!,./0,&!,./0,%

!

"

#

-,./0,% -,./0,&

0,123"4,%,5>1?":>1

@,4">,

2/034

567$

!,./0,% !,./0,&

==

=

A

!

@

!

"

()!*"+,% ()!*#+,%

@,4">,

0,123"4,%,567,88"9:

= =

7893:

()!,7893:

B

*C!0

*C!!

DE"

F

6GH 6IG

DE"

6GH 6IG

JKJKJKJK

L!F

L!F

M"#.%9N36N3

CN>1,N8

L!F

O9P%9N36N3

(5I (5Q (5R

6GH @80,<

B L!F

CN>1,N8

(5I (5Q (5R

BSI

O*@T

AU8O*V

'W3

"X>23,:":F

LYEB

L!F

L!F

M"#.%9N36N3

CN>1,N8

L!F

O9P%9N36N3

(5I (5Q (5R

Z23,7 *C!X! Z23,7 *C!X!

F.28,

L!F

6IGXB%<,4">, 6IG#XB%<,4">,

!

"

#

%

$

()!*"+,% ()!*#+,% (&),%

0,123"4,%%,5>1?":>1

@,4">,

2/034

6;<,"=

fluorescence

no fluorescence !"#$%&

' (

)

!

"

#

! "# #$ %& $'

()!*"+,%

()!*#+,%

(&),%

*"+,%-./

0,123"4,%,567,88"9:%-;91</

=

=

*"+,%-./

!

"

#

! "# #$ %& $'

-,./0,%-,./0,1

0,123"4,%,567,88"9:%-;91</

==!,./0,&!,./0,%

!

"

#

-,./0,% -,./0,&

0,123"4,%,5>1?":>1

@,4">,

2/034

567$

!,./0,% !,./0,&

==

=

A

!

@

!

"

()!*"+,% ()!*#+,%

@,4">,

0,123"4,%,567,88"9:

= =

7893:

()!,7893:

B

*C!0

*C!!

DE"

F

6GH 6IG

DE"

6GH 6IG

JKJKJKJK

L!F

L!F

M"#.%9N36N3

CN>1,N8

L!F

O9P%9N36N3

(5I (5Q (5R

6GH @80,<

B L!F

CN>1,N8

(5I (5Q (5R

BSI

O*@T

AU8O*V

'W3

"X>23,:":F

LYEB

L!F

L!F

M"#.%9N36N3

CN>1,N8

L!F

O9P%9N36N3

(5I (5Q (5R

Z23,7 *C!X! Z23,7 *C!X!

F.28,

L!F

6IGXB%<,4">, 6IG#XB%<,4">,

!

"

#

%

$

()!*"+,% ()!*#+,% (&),%

0,123"4,%%,5>1?":>1

@,4">,

2/034

6;<,"=

Molecular computers can rewire disease pathways

Culler SC, Hoff KG, Smolke CD. 2010. Science. 330: 1251-5

!"#$%&

'

(

)

!

*

+,-./,0

123 )04/5

678 & 3 9 : ; 8 < = > &? && &3 67= @!A67<

6

4/.BC"D/%!E.5%67FG/00"E+

9H00%5/D"-/ ;H00%5/D"-/

I

I

II

I

I II

I

A.BCJEGK%L%123M)04/5

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#A.BCJEGK%L%123M)04/5

4/.BC"D/%67-.NO+-.

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#

I

I

I

II

I

I

I

O+CGE+%FE0"C"E+

9H00%5/D"-/ ;H00%5/D"-/

' *

( FGE."J/GBC"E+

"+F,C%0"#+B.

PBC"D/%P/CQEGR

'.C/G/5%P/CQEGR

' *

(

"+F,C%0"#+B.

)

!"#$%&

-/..%5/BCS!"#$%'

"+F,C%KE5,./

FGEC/"+%0/+0EG

B-C,BCEG%KE5,./

$+,, &+,,

/7E+%/7-.,0"E+

TS"#S%5/D"-/

E,CF,CU

B.C/G+BC"D/%/7E+%"+-.,0"E+

L L

E,CF,C%KE5,./

#/+/%EJ%"+C/G/0C

@VO

B00/KW./5%4P'%5/D"-/

@VO

XS/%"5/+C"CY%EJ%CS/%4P'%0/+0EG%B+5%"C0%.E-BC"E+%"+%CS/%"+CGE+"-%

0FB-/%Q"..%5/C/GK"+/%CS/%/JJ/-C%

EJ%"+F,C%W"+5"+#%E+%CS/%5/D"-/%

E,CF,C$

/7E+%"+-.,0"E+

T.EQ%5/D"-/%

E,CF,CU

)04/5 123M)04/5 )04/5 123M)04/5

123M9%)/D"-/

)04/5

@!A

1/G#/5

123!M9%)/D"-/

@VO

@VO

.EQ%E,CF,C

S"#S%E,CF,C

9H00

5/D"-/

+,-./,0

FGEC/"+%

"+F,C

@VO

!"#$%&

'

(

)

!

*

+,-./,0

123 )04/5

678 & 3 9 : ; 8 < = > &? && &3 67= @!A67<

6

4/.BC"D/%!E.5%67FG/00"E+

9H00%5/D"-/ ;H00%5/D"-/

I

I

II

I

I II

I

A.BCJEGK%L%123M)04/5

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#A.BCJEGK%L%123M)04/5

4/.BC"D/%67-.NO+-.

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#

I

I

I

II

I

I

I

O+CGE+%FE0"C"E+

9H00%5/D"-/ ;H00%5/D"-/

' *

( FGE."J/GBC"E+

"+F,C%0"#+B.

PBC"D/%P/CQEGR

'.C/G/5%P/CQEGR

' *

(

"+F,C%0"#+B.

)

!"#$%&

-/..%5/BCS!"#$%'

"+F,C%KE5,./

FGEC/"+%0/+0EG

B-C,BCEG%KE5,./

$+,, &+,,

/7E+%/7-.,0"E+

TS"#S%5/D"-/

E,CF,CU

B.C/G+BC"D/%/7E+%"+-.,0"E+

L L

E,CF,C%KE5,./

#/+/%EJ%"+C/G/0C

@VO

B00/KW./5%4P'%5/D"-/

@VO

XS/%"5/+C"CY%EJ%CS/%4P'%0/+0EG%B+5%"C0%.E-BC"E+%"+%CS/%"+CGE+"-%

0FB-/%Q"..%5/C/GK"+/%CS/%/JJ/-C%

EJ%"+F,C%W"+5"+#%E+%CS/%5/D"-/%

E,CF,C$

/7E+%"+-.,0"E+

T.EQ%5/D"-/%

E,CF,CU

)04/5 123M)04/5 )04/5 123M)04/5

123M9%)/D"-/

)04/5

@!A

1/G#/5

123!M9%)/D"-/

@VO

@VO

.EQ%E,CF,C

S"#S%E,CF,C

9H00

5/D"-/

+,-./,0

FGEC/"+%

"+F,C

@VO

Native Network

Altered Network

!"#$%&

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''

!

()*%+,#-./0

)1//%2345"56/%+70

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

)1//%2345"56/%+70

()*%+,#-./0

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

8

9 )

:

; <=*>?@

A3B/132

CD; CDE CDF

()*

8GHGIHI"B

AHJ>6GHGIHI"B

<=*>?@

<=*>?@

K?:&

)L2K?M

8NI!>B6I1J"J

O

(=@P

P

!"#$

?A!"

Q@!

%

&'( &)'

Q@!

&'( &)'

*+*+*+*+

<=*>?@

A3B/132

CD; CDE CDF

()*

8GHGIHI"B

AHJ>6GHGIHI"B

<=*>?@

<=*>?@

?64#1I"J#%B1//%

R16IS%R15"B1%

T"IS%26U1IL%

I4"##14

:"21621%.64N14

O4H>R43#

8GHGIH2"2

!"#$%&

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''

!

()*%+,#-./0

)1//%2345"56/%+70

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

)1//%2345"56/%+70

()*%+,#-./0

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

8

9

)

:

;

<64#1=">#%)1//%

:16=?%:15"@1

A"=?%26B1=C%

<4"##14

:"D16D1%E64F14

G4HI43#

8JHJ=HD"D

K L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

R<:&

)CDR<S

8F=!M@6=1>">

G

(2NT

T

!"#$

<U!"

VN!

%

&'( &)'

VN!

&'( &)'

*+*+*+*+

L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

!

M<U!M" W<U!M" W<U!M"

JKXMT%:15"@1 JKX#MT%:15"@1

Y

SY

SYY

()*%+,#-./0MR<:& W%R<:& W%R<:&

!M@6=MK%:15"@1 !M@6=#MK%:15"@1

Y

SY

SYY

()*%+,#-./0

!"#$%&

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''

!

()*%+,#-./0

)1//%2345"56/%+70

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

)1//%2345"56/%+70

()*%+,#-./0

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

8

9

)

:

;

<64#1=">#%)1//%

:16=?%:15"@1

A"=?%26B1=C%

<4"##14

:"D16D1%E64F14

G4HI43#

8JHJ=HD"D

K L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

R<:&

)CDR<S

8F=!M@6=1>">

G

(2NT

T

!"#$

<U!"

VN!

%

&'( &)'

VN!

&'( &)'

*+*+*+*+

L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

!

M<U!M" W<U!M" W<U!M"

JKXMT%:15"@1 JKX#MT%:15"@1

Y

SY

SYY

()*%+,#-./0MR<:& W%R<:& W%R<:&

!M@6=MK%:15"@1 !M@6=#MK%:15"@1

Y

SY

SYY

()*%+,#-./0

cell death fate 2

proliferation fate 1

!"#$%&'(

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

))

!

*+,'-.#/012

+&11'3$%4"451'-62

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

+&11'3$%4"451'-62

*+,'-.#/012

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

))0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

5

7

8

9

&

:5%#&;"<#'+&11'

=&5;>'=&4"8&

?";>'35@&;A'

:%"##&%

="B&5B&'C5%D&%

E%F9%$#

GHFH;FB"B

I J3,K:L

<$81&$B

MNI MNO MNP

*+,

5HFH;F;"8

<F<K5HFH;F;"8

J3,K:L

J3,K:L

Q:=(

+ABQ:R

GD;!K85;&<"<

E

*3LS

S

!"#$

:T!"

UL!

%

&'( &)'

UL!

&'( &)'

*+*+*+*+

J3,K:L

<$81&$B

MNI MNO MNP

*+,

5HFH;F;"8

<F<K5HFH;F;"8

J3,K:L

J3,K:L

@

K:T!K" V:T!K" V:T!K"

HIWKS'=&4"8& HIW#KS'=&4"8&

X

RX

RXX

*+,'-.#/012KQ:=( V'Q:=( V'Q:=(

!K85;KI'=&4"8& !K85;#KI'=&4"8&

X

RX

RXX

*+,'-.#/012

Modularity allows tailoring to different diseases

Culler SC, Hoff KG, Smolke CD. 2010. Science. 330: 1251-5

!"#$%&

'

(

)

!

*

+,-./,0

123 )04/5

678 & 3 9 : ; 8 < = > &? && &3 67= @!A67<

6

4/.BC"D/%!E.5%67FG/00"E+

9H00%5/D"-/ ;H00%5/D"-/

I

I

II

I

I II

I

A.BCJEGK%L%123M)04/5

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#A.BCJEGK%L%123M)04/5

4/.BC"D/%67-.NO+-.

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#

I

I

I

II

I

I

I

O+CGE+%FE0"C"E+

9H00%5/D"-/ ;H00%5/D"-/

' *

( FGE."J/GBC"E+

"+F,C%0"#+B.

PBC"D/%P/CQEGR

'.C/G/5%P/CQEGR

' *

(

"+F,C%0"#+B.

)

!"#$%&

-/..%5/BCS!"#$%'

"+F,C%KE5,./

FGEC/"+%0/+0EG

B-C,BCEG%KE5,./

$+,, &+,,

/7E+%/7-.,0"E+

TS"#S%5/D"-/

E,CF,CU

B.C/G+BC"D/%/7E+%"+-.,0"E+

L L

E,CF,C%KE5,./

#/+/%EJ%"+C/G/0C

@VO

B00/KW./5%4P'%5/D"-/

@VO

XS/%"5/+C"CY%EJ%CS/%4P'%0/+0EG%B+5%"C0%.E-BC"E+%"+%CS/%"+CGE+"-%

0FB-/%Q"..%5/C/GK"+/%CS/%/JJ/-C%

EJ%"+F,C%W"+5"+#%E+%CS/%5/D"-/%

E,CF,C$

/7E+%"+-.,0"E+

T.EQ%5/D"-/%

E,CF,CU

)04/5 123M)04/5 )04/5 123M)04/5

123M9%)/D"-/

)04/5

@!A

1/G#/5

123!M9%)/D"-/

@VO

@VO

.EQ%E,CF,C

S"#S%E,CF,C

9H00

5/D"-/

+,-./,0

FGEC/"+%

"+F,C

@VO

!"#$%&

'

(

)

!

*

+,-./,0

123 )04/5

678 & 3 9 : ; 8 < = > &? && &3 67= @!A67<

6

4/.BC"D/%!E.5%67FG/00"E+

9H00%5/D"-/ ;H00%5/D"-/

I

I

II

I

I II

I

A.BCJEGK%L%123M)04/5

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#A.BCJEGK%L%123M)04/5

4/.BC"D/%67-.NO+-.

!

"

#

$

%

&

" # $ % & ' ( ) * "! "" "#

I

I

I

II

I

I

I

O+CGE+%FE0"C"E+

9H00%5/D"-/ ;H00%5/D"-/

' *

( FGE."J/GBC"E+

"+F,C%0"#+B.

PBC"D/%P/CQEGR

'.C/G/5%P/CQEGR

' *

(

"+F,C%0"#+B.

)

!"#$%&

-/..%5/BCS!"#$%'

"+F,C%KE5,./

FGEC/"+%0/+0EG

B-C,BCEG%KE5,./

$+,, &+,,

/7E+%/7-.,0"E+

TS"#S%5/D"-/

E,CF,CU

B.C/G+BC"D/%/7E+%"+-.,0"E+

L L

E,CF,C%KE5,./

#/+/%EJ%"+C/G/0C

@VO

B00/KW./5%4P'%5/D"-/

@VO

XS/%"5/+C"CY%EJ%CS/%4P'%0/+0EG%B+5%"C0%.E-BC"E+%"+%CS/%"+CGE+"-%

0FB-/%Q"..%5/C/GK"+/%CS/%/JJ/-C%

EJ%"+F,C%W"+5"+#%E+%CS/%5/D"-/%

E,CF,C$

/7E+%"+-.,0"E+

T.EQ%5/D"-/%

E,CF,CU

)04/5 123M)04/5 )04/5 123M)04/5

123M9%)/D"-/

)04/5

@!A

1/G#/5

123!M9%)/D"-/

@VO

@VO

.EQ%E,CF,C

S"#S%E,CF,C

9H00

5/D"-/

+,-./,0

FGEC/"+%

"+F,C

@VO

Native Network

Altered Network

!"#$%&

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''

!

()*%+,#-./0

)1//%2345"56/%+70

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

)1//%2345"56/%+70

()*%+,#-./0

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

8

9 )

:

; <=*>?@

A3B/132

CD; CDE CDF

()*

8GHGIHI"B

AHJ>6GHGIHI"B

<=*>?@

<=*>?@

K?:&

)L2K?M

8NI!>B6I1J"J

O

(=@P

P

!"#$

?A!"

Q@!

%

&'( &)'

Q@!

&'( &)'

*+*+*+*+

<=*>?@

A3B/132

CD; CDE CDF

()*

8GHGIHI"B

AHJ>6GHGIHI"B

<=*>?@

<=*>?@

?64#1I"J#%B1//%

R16IS%R15"B1%

T"IS%26U1IL%

I4"##14

:"21621%.64N14

O4H>R43#

8GHGIH2"2

!"#$%&

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''

!

()*%+,#-./0

)1//%2345"56/%+70

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

)1//%2345"56/%+70

()*%+,#-./0

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

8

9

)

:

;

<64#1=">#%)1//%

:16=?%:15"@1

A"=?%26B1=C%

<4"##14

:"D16D1%E64F14

G4HI43#

8JHJ=HD"D

K L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

R<:&

)CDR<S

8F=!M@6=1>">

G

(2NT

T

!"#$

<U!"

VN!

%

&'( &)'

VN!

&'( &)'

*+*+*+*+

L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

!

M<U!M" W<U!M" W<U!M"

JKXMT%:15"@1 JKX#MT%:15"@1

Y

SY

SYY

()*%+,#-./0MR<:& W%R<:& W%R<:&

!M@6=MK%:15"@1 !M@6=#MK%:15"@1

Y

SY

SYY

()*%+,#-./0

!"#$%&

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''

!

()*%+,#-./0

)1//%2345"56/%+70

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

)1//%2345"56/%+70

()*%+,#-./0

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

''0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

8

9

)

:

;

<64#1=">#%)1//%

:16=?%:15"@1

A"=?%26B1=C%

<4"##14

:"D16D1%E64F14

G4HI43#

8JHJ=HD"D

K L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

R<:&

)CDR<S

8F=!M@6=1>">

G

(2NT

T

!"#$

<U!"

VN!

%

&'( &)'

VN!

&'( &)'

*+*+*+*+

L2*M<N

>3@/13D

;OK ;OP ;OQ

()*

6JHJ=H="@

>H>M6JHJ=H="@

L2*M<N

L2*M<N

!

M<U!M" W<U!M" W<U!M"

JKXMT%:15"@1 JKX#MT%:15"@1

Y

SY

SYY

()*%+,#-./0MR<:& W%R<:& W%R<:&

!M@6=MK%:15"@1 !M@6=#MK%:15"@1

Y

SY

SYY

()*%+,#-./0

cell death fate 2

proliferation fate 1

!"#$%&'(

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

))

!

*+,'-.#/012

+&11'3$%4"451'-62

!'()*"'$+,-./#!'()*'$+'-./#!'()*'$+,-./#

+&11'3$%4"451'-62

*+,'-.#/012

!

"!

#!

$!

%!

&!!

&"!

& &! &!!

))0$1"'2+,.34'#

0$1'2+'.34'#

0$1'2+,.34'#

!

5

7

8

9

&

:5%#&;"<#'+&11'

=&5;>'=&4"8&

?";>'35@&;A'

:%"##&%

="B&5B&'C5%D&%

E%F9%$#

GHFH;FB"B

I J3,K:L

<$81&$B

MNI MNO MNP

*+,

5HFH;F;"8

<F<K5HFH;F;"8

J3,K:L

J3,K:L

Q:=(

+ABQ:R

GD;!K85;&<"<

E

*3LS

S

!"#$

:T!"

UL!

%

&'( &)'

UL!

&'( &)'

*+*+*+*+

J3,K:L

<$81&$B

MNI MNO MNP

*+,

5HFH;F;"8

<F<K5HFH;F;"8

J3,K:L

J3,K:L

@

K:T!K" V:T!K" V:T!K"

HIWKS'=&4"8& HIW#KS'=&4"8&

X

RX

RXX

*+,'-.#/012KQ:=( V'Q:=( V'Q:=(

!K85;KI'=&4"8& !K85;#KI'=&4"8&

X

RX

RXX

*+,'-.#/012

Advancing cell-based therapies

Chen YY, Jensen MC, Smolke CD. 2010. PNAS. 107: 8531-6

Cellular therapies: engineering the immune system

http://www.discoverymedicine.com/Leslie-E-Huye/files/2010/03/

harvest lymphocytes from patient recover and engineer

desired cell type

transfer engineered cells into patient

T-cell proliferation pathway

!"#$ !"#$

!" !"

%&"&$!"%&"&$ !"

#$%&'()*"

+,-,".(/*0(123&)"2)."

)4#5*20"%02)65&#23&)"

*780*66(&)"&9"

:0&;%<=

0*52%*.":*)*6""

!"

!"

!"!"

!"#$

!"#$

!"#$%&'()

#*+,'-*,+)

&.&,$)

#*+,'-)

'("-*/*0'$*1,)

0'#0'2&)

"'$34'5)

1!$"!$)

!"#$%&'()

*+#$,+--&,)

Chen YY, Jensen MC, Smolke CD. 2010. PNAS. 107: 8531-6

A molecular computer controlling immune response

Chen YY, Jensen MC, Smolke CD. 2010. PNAS. 107: 8531-6

proliferation

apoptosis / death

A molecular computer controlling immune response

No drug

With drug

Chen YY, Jensen MC, Smolke CD. 2010. PNAS. 107: 8531-6

0.0E+00

2.0E+08

4.0E+08

6.0E+08

8.0E+08

1.0E+09

1.2E+09

0 2 4 6 8 10 12 14 16 F

lux (

ph

oto

ns/s

ec)

Days Post Injection

L2bulge9(3x) 0 uM Theo

L2bulge9(3x) 500 uM Theo

!"#$%&'()*+,-./-01'/-

!"#$%&'()*+,-233-45-01'/-

Apps

Tools

Device Design

AGGTACAGTTATCA CCCATTGCATGGTA TTCAAAGAAGTCGT GGCCCAGATTCGAC AAATCGTGTAGTAA TGGTCCAGCTGATT GGTTCAAATAACGG

input A

outp

ut

Languages & Grammar Standardization Abstraction Synthesis

The Smolke Laboratory

Alfred P. Sloan Foundation Arnold and Mabel Beckman Foundation Bill and Melinda Gates Foundation Defense Advanced Research Projects Agency National Institutes of Health (NIGMS, NCI) National Science Foundation (CBET, CCF, CAREER)

Funding Sources Andrew Babiskin Travis Bayer Chase Beisel Yvonne Chen Stephanie Culler Kristy Hawkins Kevin Hoff Maung Nyan Win

Alumni

Let’s design with DNA…

top related